Microemulsion drug delivery system: Design and development for oral bioavailability enhancement of lovastatin

SA Pharmaceutical Journal

Volumn 78, Issue 3, 2011, Pages 44-50

  Mandal, Surjyanarayan ^a  

^a M S UNIVERSITY OF BARODA   (India)

Author keywords

Bioavailability; HMG CoA reductase; Lovastatin; ME; Zeta potential

Indexed keywords

CREMOPHOR; MEVINOLIN; PLACEBO;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MICROEMULSION; NONHUMAN; PARTICLE SIZE; PHASE SEPARATION; RAT; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; VISCOSITY; ZETA POTENTIAL;

EID: 79955924784     PISSN: 10151362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lennernas H, Fager G. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharmacokinet. 1997;32:403-405.
2. Kohsaku K, Takayoshi Y. Microemulsion formulation for enhanced absorbtion of poorly soluble drug I. Prescription Design. J Control Release. 2002;81:65-74.
3. Charman WN, Stella VJ. Transport of lipophilic molecules by the intestinal lymphatic system. Adv Drug Del Rev. 1991;7:1-14.
4. Brittain HG, Florey K. Analytical profiles of drug substances and excipients. Lovastatin. New York: Academic Press; 1992.
5. Kang BK, Lee JS, Chon SK, et al. Development of microemulsion drug delivery system for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm. 2004;274:65-73. (Pubitemid 38457007)
6. Patel D, Sawant KK. Oral bioavailability enhancement of acyclovir by self microemulsifying drug delivery systems. Drug Dev Ind Pharm. 2007;33:1318-1326.
7. Abbofazeli R, Lawrence MJ. Investigation into the formation and characterisation of phospholipids ME.II: pseudoternary phase diagram of system containing water-lecithin-isopropyl myristate and alcohol: influence of purity of lecithin. Int J Pham. 1994;106:51-61.
8. Acharya A, Sanyal SK, Moulik SP. Formation and characterisation of pharmaceutically useful microemulsion derived from isopropyl myristate, Brij 30, isopropyl alcohol and water. Current Science. 2001;8:362-370. (Pubitemid 33624422)
9. Kawtikwar PS, Kulkarni NP, Yadav S, Sakarkar DM. Formulation and evaluation of an anti-epileptic, drug-loaded microemulsion for nose to brain delivery. Asian Journal of Pharmaceutics. 2009; 20:143-147.
10. Talegaonkar S, Azeem A, Ahmad FJ, et al. Microemulsions: a novel approach to enhance drug delivery. Recent Pat Drug Deliv Formul. 2008;2:238-257.
11. Ghosh PK, Umrethia M, Majithiya RJ, Murthy RSR. Preparation and physicochemical characterisation of aprylocapryl macrogol -8-glycerides microemulsion for oral drug delivery. Ars Pharm. 2004;45:353-372. (Pubitemid 41301630)
12. Hiroshi A, Mikio T, Masahiro H. The novel formulation design of o/w microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds. Int J Pharm. 2005;305: 61-74.
13. Zhifei Z, Zhaoyong Y. HPLC determination of lovastatin in rat tissue. Chromatographia. 2007;66:487-491.
14. Rajh SJ, Kreft S, Strukelj B, Vrecer F. Comparision of CE and HPLC method for determining lovastatin and its oxidation products after exposure to an oxidative atmosphere. Croat Chem Acta. 2003;76:263-268. (Pubitemid 38333513)
15. Bangaru RA, Bansal YK, Rao ARM, Gandhi TP. Rapid, simple, and sensitive high-performance liquid chromatographic method for detection and determination of acyclovir in human plasma and its use in bioavailability studies. J. Chromatogr. 2000;739:231-237. (Pubitemid 30125409)
16. Eldridge JH, Hammond CJ, Meulbrock JA, et al. Controlled vaccine release in the gut-associated lymphoid tissue, I: orally administered biodegradable microspheres target the Payer's patches. J Control Release. 1990;11: 205-214.